期刊文献+

慢病毒载体介导增强型绿色荧光蛋白转导兔角膜上皮细胞的体外实验研究 被引量:2

Lentivirus vector-mediated enhanced green fluorescence protein transfection on in vitro corneal epithelial cells of rabbits
下载PDF
导出
摘要 目的观察慢病毒载体(lentiviral vectors,LVs)用于兔角膜上皮细胞基因转染的有效性。方法兔角膜上皮细胞的原代及传代培养并做细胞鉴定;慢病毒载体介导的增强型绿色荧光蛋白(lenti-EGFP)以不同的感染复数(multiplicity of infection,MOI=0、1、10、50、100、500)转染实验细胞,寻找最佳转染剂量;于转染后24、48、72、96h运用倒置荧光显微镜观察不同MOI下增强型绿色荧光蛋白(enhanced green fluorescence protein,EGFP)的表达并计算细胞转染率;RT-PCR方法检测EGFP基因的表达情况。结果 EGFP于转染48h即开始有表达,随着转染时间的延长其表达增强。MOI=1、10、50、100时,角膜上皮细胞转染率随着感染复数的增加而增加,分别为(4.5±0.6)%、(30.4±0.9)%、(51.9±1.4)%、(75.4±0.7)%,各组间差异显著(P<0.05);MOI在100与500时,转染率差异不显著(P>0.05),即最适感染复数为100。RT-PCR结果提示转染细胞组EGFP基因有表达。结论慢病毒载体能够有效转染离体兔角膜上皮细胞。 Objective To observe the effect of lentivirus vector-medicated enhanced green fluorescence protein (EGFP) transfection on in vitro corneal epithelial cells.Methods Primary corneal epithelial cells of rabbits were cultured and transfected with lentivirus vector into different multiplicity of infection (MOI) in order to find the best transfection dose.After 24,48,72,and 96 h of transfection,expression of EGFP was observed under microscope and detected by RT-PCR.The transfection rate of corneal epithelial cells was calculated in different MOI.Results EGFP was expressed in corneal epithelial cells 48 h after transfection,which increased with the increasing transfection time.The transfection rate of corneal epithelial cells was 4.5%±0.6%,30.4%±0.9%,51.9%±1.4%,and 75.4%±0.7%,respectively,when MOI was 1,10,50,and 100(P0.05).However,no difference was found in the transfection rate of corneal epithelial cells when MOI was 100 and 500.The optimol MOI was 100.RT-PCR showed that EGFP gene was expressed in transfected corneal epithelial cells.Conclusion Lentivirus vector can effectively transfect corneal epithelial cells in vitro.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第13期1425-1428,共4页 Journal of Third Military Medical University
关键词 慢病毒 基因转染 角膜上皮 有效性 细胞实验 lentivirus gene transfection corneal epithelial cell effectiveness in vitro
  • 相关文献

参考文献15

  • 1Pawelczyk E, Jordan E K, Balakumaran A, et al. In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages[ J ]. PLoS One, 2009, 4 (8) : e6712.
  • 2Siwko S K, Bu W, Gutierrez C, et al. Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors[ J]. Neoplasia, 2008, 10(7) : 653 -662.
  • 3李宁,朱宝长,朱宛宛,王淑艳,任萍,关云谦,张愚.慢病毒介导绿色荧光蛋白转染人胚胎干细胞及其培养[J].基础医学与临床,2008,28(10):1083-1087. 被引量:6
  • 4Patrick L S, Ariadna C A, Kim A B, et al. Lentivirus vector can be readministered to nasal epithelia without blocking immune responses[J].JVirol, 2008, 82(21): 10684 -10692.
  • 5Humeau L M, Binder G K, Lu X, et al. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV + infected patients grouped according to CD4 count and viral load [J]. Mol Ther, 2004, 9(6) : 902 -913.
  • 6Yoon KC, Bae JA, Park H J, et al. Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse model[J]. Gene Ther, 2009, 16(8) : 973 -981.
  • 7Jun A S, Larkin D F. Prospects for gene therapy in corneal disease [J]. Eye, 2003, 17(8):906-911.
  • 8Williams K A, Coster D J. Gene therapy for diseases of the cornea- a review [ J]. Clin Experiment Ophthalmol, 2010, 38 (2) : 93 - 103.
  • 9Parker D G, Kaufmann C, Brereton H M, et al. Lentivirus-mediated gene transfer to the rat, ovine and human cornea [J]. Gene Ther, 2007, 14(9) : 760 -767.
  • 10Birraux J, Wildhaber B E, Jond C, et al. Ex vivo hepatocyte gene therapy: increased biosafety protocol for transduction in suspension with lentiviral vectors and immediate transplantation (SLIT) [ J ]. Transplantation, 2010, 89(1 ): 127-9.

二级参考文献1

共引文献5

同被引文献13

  • 1Wu X,Li Y,Crise B,et al.Transcription start regions in the human genome are favored targets for MLV integration[J].Science,2003,300 (5626):1749-1751.
  • 2Lemiale F,Korokhov N.Lentiviral vectors for HIV disease prevention and treatment[J].Vaccine,2009,27(25-26):3443-3449.
  • 3Fernandez Vallone VB, Romaniuk MA, Choi H, et al. Mesenchymal stem cells and their use in therapy :what has been achieved[ J]. Dif- ferentiation,2013,85 : 1 - 10. cells: in vitro strategies[ J]. Methods Mol Biol,2011, 698:305-314.
  • 4Nakamura A, Dohi Y, Akahane M, et al. Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells[ J]. Tissue Eng Part C Methods,2009,15 : 169 - 180.
  • 5Tang X, Sheng L, Xie F, et al. Differentiation of bone marrow - de- rived mesenchymal stem cells into chondrocytes using chondrocyte extract[ J]. Mol Med Rep ,2012,6:745 -749.
  • 6Ninomiya Y, Sugahara - Yamashita Y, Nakachi Y, et al. Development of a rapid culture method to induce adipocyte differentiation of human bone marrow -derived mesenchymal stem cells[ J]. Biochem Biophys Res Commun ,2010,394:303 - 308.
  • 7Khoo ML, Shen B, Tao H, et al. Long - term serial passage and neuro- nal differentiation capability of human bone marrow mesenchymal stem cells[J]. Stem Cells Dev,2008 ,17 :883 - 896.
  • 8Snykers S, De Kock J, Tamara V, et al. Hepatic differentiation of mes- enchymal stem cells: in vitro strategies[ Jl. Methods Mol Biol,2011, 698:305-314.
  • 9Bauer G, Dao MA, Case SS, et al. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors [ J ]. Mol Ther,2008,16 : 1308 - 1315.
  • 10Stephens D J, Allan VJ. Light microscopy techniques for live cell ima- ging[ J]. Science ,2003,300 : 82 - 86.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部